{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:42:17Z","timestamp":1787312537241,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50-MH077083"],"award-info":[{"award-number":["P50-MH077083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG061359"],"award-info":[{"award-number":["U01AG061359"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["M01-RR0039"],"award-info":[{"award-number":["M01-RR0039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG046171"],"award-info":[{"award-number":["R01AG046171"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-MH080880"],"award-info":[{"award-number":["R01-MH080880"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1-RR025008"],"award-info":[{"award-number":["UL1-RR025008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH108348"],"award-info":[{"award-number":["R01MH108348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jad.2025.01.064","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:46:11Z","timestamp":1736876771000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder"],"prefix":"10.1016","volume":"375","author":[{"given":"Sudeepa","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"MahmoudianDehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Sniatynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Belenky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasant R.","family":"Marur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Edward","family":"Craighead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Mayberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Kristal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.01.064_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.04.017","article-title":"Purine metabolism is dysregulated in patients with major depressive disorder","volume":"70","author":"Ali-Sisto","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.9758\/cpn.2014.12.1.37","article-title":"Duloxetine, a selective noradrenaline reuptake inhibitor, increased plasma levels of 3-methoxy-4-hydroxyphenylglycol but not homovanillic acid in patients with major depressive disorder","volume":"12","author":"Atake","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"4","key":"10.1016\/j.jad.2025.01.064_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5498\/wjp.v13.i4.141","article-title":"Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder","volume":"13","author":"Badawy","year":"2023","journal-title":"World J. Psychiatr."},{"issue":"8","key":"10.1016\/j.jad.2025.01.064_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160542","article-title":"Branched-chain amino acids as new biomarkers of major depression - a novel neurobiology of mood disorder","volume":"11","author":"Baranyi","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41398-019-0507-5","article-title":"Metabolomic signature of exposure and response to citalopram\/escitalopram in depressed outpatients","volume":"9","author":"Bhattacharyya","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.064_bb0030","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3389\/fnins.2019.00926","article-title":"Pilot study of metabolomic clusters as state markers of major depression and outcomes to CBT treatment","volume":"13","author":"Bhattacharyya","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0035","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1038\/s41598-021-99845-1","article-title":"Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature","volume":"11","author":"Brydges","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.01.064_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1745-6215-13-106","article-title":"Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial","volume":"13","author":"Dunlop","year":"2012","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.jad.2025.01.064_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/appi.ajp.2016.16050518","article-title":"Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder","volume":"174","author":"Dunlop","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2025.01.064_bb0050","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1176\/appi.ajp.2016.16050517","article-title":"Effects of patient preferences on outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study","volume":"174","author":"Dunlop","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.01.064_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1176\/appi.ajp.2018.18091075","article-title":"Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression","volume":"176","author":"Dunlop","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2025.01.064_bb0060","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/npp.2014.333","article-title":"A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial","volume":"40","author":"Etkin","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.01.064_bb0065","series-title":"SCID-I: User\u2019s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders","author":"First","year":"1997"},{"issue":"12","key":"10.1016\/j.jad.2025.01.064_bb0070","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/mp.2016.6","article-title":"TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics","volume":"21","author":"Gupta","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.064_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2022.09.001","article-title":"Regional metabolic heterogeneity in anterior cingulate cortex in major depressive disorder: a multi-voxel (1)H magnetic resonance spectroscopy study","volume":"318","author":"He","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.01.064_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2019.02.063","article-title":"Plasma serotonin levels are associated with antidepressant response to SSRIs","volume":"250","author":"Holck","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2025.01.064_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2015.17.2\/dionescu","article-title":"Pharmacological approaches to the challenge of treatment-resistant depression","volume":"17","author":"Ionescu","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jad.2025.01.064_bb0100","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/tp.2011.22","article-title":"Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept","volume":"1","author":"Kaddurah-Daouk","year":"2011","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12937-021-00670-z","article-title":"Dietary intake of branched-chain amino acids in relation to depression, anxiety and psychological distress","volume":"20","author":"Koochakpoor","year":"2021","journal-title":"Nutr. J."},{"issue":"4","key":"10.1016\/j.jad.2025.01.064_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/14728222.2018.1452912","article-title":"Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy","volume":"22","author":"Kulikov","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.jad.2025.01.064_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/ebmh.6.2.45","article-title":"Review: antidepressants and psychotherapy may be equally effective for promoting remission in major depressive disorder","volume":"6","author":"Lam","year":"2003","journal-title":"Evid. Based Ment. Health"},{"issue":"4","key":"10.1016\/j.jad.2025.01.064_bb0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145704004699","article-title":"Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response","volume":"7","author":"Lemonde","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.01.064_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41398-020-01097-6","article-title":"Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram\/escitalopram in major depression","volume":"11","author":"MahmoudianDehkordi","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2025.01.064_bb0130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/bdi.13035","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disord."},{"issue":"5","key":"10.1016\/j.jad.2025.01.064_bb0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bdi.13251","article-title":"NICE guideline for depression ranks short-term psychodynamic psychotherapy (STTP)","volume":"24","author":"Malhi","year":"2022","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jad.2025.01.064_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.2022.133","article-title":"The management of depression: the evidence speaks for itself","volume":"222","author":"Malhi","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.01.064_bb0145","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study","volume":"32","author":"Okamoto","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.01.064_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.145","article-title":"Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants","volume":"6","author":"Rotroff","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.064_bb0155","series-title":"Side Effects of Drugs Annual","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.seda.2022.07.001","article-title":"Side effects of antidepressants","author":"Salwan","year":"2022"},{"issue":"3","key":"10.1016\/j.jad.2025.01.064_bb0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/02698811221104058","article-title":"Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression","volume":"37","author":"Scott","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.01.064_bb1000","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/abio.2001.5568","article-title":"Attention to relative response across sequential electrodes improves quantitation of coulometric array","volume":"302","author":"Shi","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jad.2025.01.064_bb1005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11306-005-1109-1","article-title":"Analytical precision, biological variation, and mathematical normalization in high data density metabolomics","volume":"1","author":"Shurubor","year":"2005","journal-title":"Metabolomics"},{"key":"10.1016\/j.jad.2025.01.064_bb1010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11306-005-4431-8","article-title":"Relative contribution of specific sources of systematic errors and analytical imprecision to metabolite analysis by HPLC\u2013ECD","volume":"1","author":"Shurubor","year":"2005","journal-title":"Metabolomics"},{"key":"10.1016\/j.jad.2025.01.064_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114655","article-title":"Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: a pilot hypothesis generating study","volume":"314","author":"Singh","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.01.064_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.140","article-title":"Targeted metabolomics and medication classification data from participants in the ADNI1 cohort","volume":"4","author":"St John-Williams","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.jad.2025.01.064_bb0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbi.2020.01.011","article-title":"The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine","volume":"87","author":"Sun","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.01.064_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2022.09.001","article-title":"Heterogeneity in major depressive disorder: the need for biomarker-based personalized treatments","volume":"112","author":"Suseelan","year":"2023","journal-title":"Adv. Clin. Chem."},{"issue":"5","key":"10.1016\/j.jad.2025.01.064_bb0185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1176\/ajp.2007.164.5.739","article-title":"Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report","volume":"164","author":"Thase","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.064_bb1015","doi-asserted-by":"crossref","first-page":"924S","DOI":"10.1093\/jn\/131.3.924S","article-title":"Characterization of Diet-Dependent Metabolic Serotypes: Analytical and Biological Variability Issues in Rats","author":"Vigneau-Callahan","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.jad.2025.01.064_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.935858","article-title":"Branched-chain amino acids linked to depression in young adults","volume":"16","author":"Whipp","year":"2022","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2025.01.064_bb0195","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cmet.2024.03.010","article-title":"Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity","volume":"36","author":"Zhao","year":"2024","journal-title":"Cell Metab."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:30:15Z","timestamp":1763663415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S0165032725000813"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.01.064","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.01.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}